Mirati Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2012 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Mirati Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2012 to Q3 2023.
  • Mirati Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$162M, a 6.72% increase year-over-year.
  • Mirati Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$726M, a 1.64% increase year-over-year.
  • Mirati Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$741M, a 27.3% decline from 2021.
  • Mirati Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$582M, a 62.5% decline from 2020.
  • Mirati Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$358M, a 67.8% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$726M -$162M +$11.7M +6.72% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$738M -$177M -$468K -0.27% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$737M -$185M +$3.8M +2.02% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$741M -$202M -$2.86M -1.43% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 -$738M -$174M -$93.5M -117% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$645M -$176M -$10M -6.02% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$634M -$188M -$52.7M -38.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$582M -$200M -$98.5M -97.5% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-28
Q3 2021 -$483M -$80.1M +$7.28M +8.34% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$491M -$166M -$83.6M -101% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$407M -$136M -$49M -56.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$358M -$101M -$28.7M -39.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$329M -$87.3M -$33.1M -60.9% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-28
Q2 2020 -$296M -$82.9M -$37.2M -81.3% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-28
Q1 2020 -$259M -$86.7M -$45.7M -112% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-28
Q4 2019 -$213M -$72.4M -$44.1M -156% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$169M -$54.3M -$26.7M -96.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$142M -$45.7M -$17.8M -64% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$125M -$40.9M -$26.2M -178% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$98.4M -$28.3M -$10.4M -58% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$88M -$27.6M -$11.2M -68.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$76.8M -$27.9M -$9.53M -52% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$67.3M -$14.7M +$3.14M +17.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$70.4M -$17.9M +$1.83M +9.26% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$72.3M -$16.4M +$3.07M +15.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$75.3M -$18.3M +$3.72M +16.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$79.1M -$17.8M +$4.07M +18.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$83.1M -$19.7M -$1.31M -7.09% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$81.8M -$19.4M -$680K -3.63% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$81.1M -$22.1M -$6.62M -42.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$74.5M -$21.9M -$9.97M -83.5% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$64.5M -$18.4M -$8.03M -77.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-09
Q3 2015 -$56.5M -$18.7M -$10.1M -117% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-09
Q2 2015 -$46.4M -$15.4M -$4.41M -39.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-09
Q1 2015 -$42M -$11.9M +$1.72M +12.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-09
Q4 2014 -$43.7M -$10.4M +$845K +7.52% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$44.5M -$8.62M +$20.8M +70.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$65.3M -$11M -$3.03M -37.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$62.3M -$13.7M -$9.44M -224% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$52.9M -$11.2M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-09
Q3 2013 -$29.4M -$23.5M -394% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$8.01M -$3.34M -71.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$4.22M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q3 2012 -$5.95M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$4.68M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.